Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a common nasal spray tame COVID-19 symptoms?

NCT ID NCT06008860

First seen Nov 10, 2025 · Last updated May 22, 2026 · Updated 26 times

Summary

This study tests whether Astepro nasal spray can help manage early COVID-19 symptoms and lower the amount of virus in adults. About 280 people with a positive COVID-19 test will use the spray or a placebo for 10 days. Researchers will track symptoms, viral load, and whether the spray reduces spread to close contacts.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COVID-19 are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Chicago

    RECRUITING

    Chicago, Illinois, 60637, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

    Contact

    Contact

Conditions

Explore the condition pages connected to this study.